Michael Hüll
Impact in
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
Papers in
- Pharmacology 15
- Inflammatory mediators and NSAID effects 7
- Cholinesterase and Neurodegenerative Diseases 6
- Physiology 13
- Alzheimer's disease research and treatments 11
- Co-authors
- Bernd L. Fiebich (13 shared papers)Klaus Lieb (8 shared papers)Johannes C. M. Schlachetzki (1 shared paper)Eduardo Candelario‐Jalil (4 shared papers)Teresa León (2 shared papers)Teodoro del Ser (2 shared papers)Bruno Dubois (2 shared papers)Simon Lovestone (2 shared papers)
- Journals
- Journal of Neurochemistry (4 papers)Current Alzheimer Research (3 papers)Glia (2 papers)Alzheimer s & Dementia (2 papers)Atmospheric Environment (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Michael Hüll
40 papers receiving 1.6k citations
Michael Hüll's Hit Papers
Peers
Comparison fields: 5 of 104
- Neurology 335
- Biological Psychiatry 77
- Physiology 675
- Pharmacology 349
- Psychiatry and Mental health 213
Countries citing papers authored by Michael Hüll
This map shows the geographic impact of Michael Hüll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hüll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hüll more than expected).
Fields of papers citing papers by Michael Hüll
This network shows the impact of papers produced by Michael Hüll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hüll. The network helps show where Michael Hüll may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Hüll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Phase II Trial of Tideglusib in Alzheimer's Disease Hit paper breakdown → | 2015 | 437 |
| 2 | 2006 | 207 | |
| 3 | 2005 | 125 | |
| 4 | 1997 | 88 | |
| 5 | 2009 | 88 | |
| 6 | 2007 | 81 | |
| 7 | 2008 | 74 | |
| 8 | 1996 | 56 | |
| 9 | 2017 | 49 | |
| 10 | 2000 | 45 | |
| 11 | 2006 | 42 | |
| 12 | 2009 | 42 | |
| 13 | 2003 | 41 | |
| 14 | 2005 | 35 | |
| 15 | 1996 | 32 | |
| 16 | 2015 | 31 | |
| 17 | 2006 | 28 | |
| 18 | 2022 | 21 | |
| 19 | 2018 | 17 | |
| 20 | 2014 | 17 |
About Michael Hüll
Michael Hüll is a scholar working on Pharmacology, Physiology, Molecular Biology, Neurology and Psychiatry and Mental health, having authored 45 papers that have together received 1.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (11 papers), Inflammatory mediators and NSAID effects (7 papers), Cholinesterase and Neurodegenerative Diseases (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Dementia and Cognitive Impairment Research (5 papers), Computational Drug Discovery Methods (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Neurology (335 citations), Biological Psychiatry (77 citations), Physiology (675 citations), Pharmacology (349 citations) and Psychiatry and Mental health (213 citations). Michael Hüll has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Bernd L. Fiebich, Klaus Lieb, Johannes C. M. Schlachetzki, Eduardo Candelario‐Jalil, Teresa León, Teodoro del Ser, Bruno Dubois, Simon Lovestone, Miguel Calero and Hans‐Jürgen Huppertz. Their work appears in journals such as Journal of Neurochemistry, Current Alzheimer Research, Glia, Alzheimer s & Dementia and Atmospheric Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.